U.S. markets close in 8 minutes
  • S&P 500

    4,206.34
    +83.87 (+2.03%)
     
  • Dow 30

    33,269.67
    +495.26 (+1.51%)
     
  • Nasdaq

    12,848.53
    +354.60 (+2.84%)
     
  • Russell 2000

    1,969.33
    +56.44 (+2.95%)
     
  • Crude Oil

    91.72
    +1.22 (+1.35%)
     
  • Gold

    1,787.80
    -6.20 (-0.35%)
     
  • Silver

    20.52
    +0.04 (+0.19%)
     
  • EUR/USD

    1.0306
    +0.0088 (+0.87%)
     
  • 10-Yr Bond

    2.7860
    -0.0110 (-0.39%)
     
  • GBP/USD

    1.2222
    +0.0146 (+1.21%)
     
  • USD/JPY

    132.9350
    -2.1810 (-1.61%)
     
  • BTC-USD

    23,636.81
    +574.16 (+2.49%)
     
  • CMC Crypto 200

    557.60
    +26.38 (+4.97%)
     
  • FTSE 100

    7,507.11
    +18.96 (+0.25%)
     
  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Top Biotech Stocks for Q3 2022

·5 min read
Top Biotech Stocks for Q3 2022
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The biotechnology industry includes companies that develop drugs and diagnostic technologies for the treatment of diseases and medical conditions. Many biotech companies have shifted their focus entirely or added COVID-19 vaccines and treatments to their product pipeline. Early-stage biotech companies are prone to wild swings in revenue due to going from nearly no revenue to having a significant revenue stream once a drug is approved or a partnership with another company is reached.